表紙
市場調查報告書

美國的臍帶血銀行服務市場分析與預測:各銀行類型、要素(臍帶血、臍帶組織、胎盤)、各州(德克薩斯州、亞利桑那州、加州、佛羅里達州、肯塔基州、紐澤西州)2014年∼2025年

U.S. Cord Blood Banking Services Market Analysis By Bank Type, By Component (Cord Blood, Tissue, Placenta), By States (Texas, Arizona, California, Florida, Kentucky, New Jersey), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 600777
出版日期 內容資訊 英文 80 Pages
商品交期: 2-3個工作天內
價格
Back to Top
美國的臍帶血銀行服務市場分析與預測:各銀行類型、要素(臍帶血、臍帶組織、胎盤)、各州(德克薩斯州、亞利桑那州、加州、佛羅里達州、肯塔基州、紐澤西州)2014年∼2025年 U.S. Cord Blood Banking Services Market Analysis By Bank Type, By Component (Cord Blood, Tissue, Placenta), By States (Texas, Arizona, California, Florida, Kentucky, New Jersey), And Segment Forecasts, 2014 - 2025
出版日期: 2017年12月04日內容資訊: 英文 80 Pages
簡介

美國的臍帶血銀行服務市場,預計2025年達到491億美元。長期性的臍帶血保存的優點,經營者數的增加,保存成本的削減,公共銀行的投資增加等,成為這個市場的主要成長要素。

本報告提供美國的臍帶血銀行服務市場相關調查,市場概要,各銀行類型、要素,各州的市場趨勢,市場規模的變化與預測,市場成長要素分析,市場佔有率,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 調查方法

  • 資訊採購
  • 資訊、資料分析
  • 市場估計:各地區
  • 2次資訊來源的清單

第2章 摘要整理

  • 市場概述

第3章 美國的臍帶血銀行服務市場

  • 市場區隔和範圍
  • 普及與成長預測製圖
  • SWOT分析
  • 產業分析 - 波特的五力分析
  • 市場機會分析
  • 保存地方分析:各銀行類型

第4章 美國的臍帶血銀行服務市場趨勢與預測:各銀行類型

  • 市場趨勢分析:各銀行類型
  • 民營資料庫
  • 公共銀行
  • 混合型銀行

第5章 美國的臍帶血銀行服務市場趨勢與預測:各要素

  • 市場趨勢分析:各要素
  • 臍帶血
  • 臍帶組織
  • 胎盤

第6章 美國的臍帶血銀行服務市場趨勢與預測:各地區

  • 美國
  • 亞利桑那州
  • 加州
  • 佛羅里達州
  • 肯塔基州
  • 紐澤西州
  • 德克薩斯州
  • 休斯頓州
  • 麻薩諸塞州

第7章 競爭情形

  • 策略架構
  • 熱圖分析:各地區
  • 企業簡介
目錄
Product Code: GVR-2-68038-054-5

The U.S. cord blood banking market is expected to reach USD 49.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing awareness regarding long term benefits of cord blood storage, increasing number of service providers, reduction in cost involved in storage, and growing investment in public banking are the factors driving the market growth in the country.

The U.S. cord blood banking market captures a significant share of the global cord blood banking industry. Factors such as high adoption rate for advanced technologies, growing per capita income, and increasing number of storage service providers can be attributable to the largest market share.

Growing applications of cord blood in the treatment of several chronic disorders is expected to fuel the market. Currently cord blood is approved for usage in around 80 diseases. These disease include degenerative disorders such as cancers, immunodeficiency related disorders, and bone marrow disorders. Growing prevalence of such diseases and need for effective therapeutic treatments are expected to boost the number of units stored. A large number of ongoing clinical trials in phase II, III, and IV are showing a potential growth opportunity in the near future.

Further Key Findings from the Report Suggest:

  • Private banking currently captures the largest revenue share and is expected to dominate the market throughout the forecast period
  • Large number of parents opting for private banking, high prices involved in collection, transport and storage, and increasing number of these type of service provides are the prime factors expected to result in swift growth of the segment during the forecast period
  • Increasing awareness, high government investment, and efforts to store genetically diverse cord blood units are the factors expected to boost the segment growth of public banking
  • Cord blood captured the largest market share in 2016 over cord tissue and placenta. Relatively easy license acquisition, affordability, and ease of storage are the factors driving the segment share.
  • Key market players include California Cryobank Stem Cell Services LLC; Cord Blood America, Inc.; StemCyte, Inc.; Norton Healthcare, Inc.; Cryo-Cell International, Inc., and Lifeforce Cryobank Sciences Inc.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information procurement
  • 1.2 Information or Data Analysis
    • 1.2.1 Market Formulation & Validation
  • 1.3 Region Wise Market Calculation
    • 1.3.1 Region Wise Market: Base Estimates
    • 1.3.2 Global Market: CAGR Calculation
  • 1.4 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 U.S. Cord Blood Banking Services Market Variables, Trends & Scope

  • 3.1 Market segmentation & scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Rising application of cord blood in treatment of chronic conditions
      • 3.1.1.2 Rising focus of federal agencies to set up public banking units
      • 3.1.1.3 Growing awareness regarding this treatment line
      • 3.1.1.4 Increasing number of facilities across the region
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 High cost and probability of non-usage
      • 3.1.2.2 Market is highly driven by recommendation made by gynecologists
  • 3.2 Penetration & growth prospect mapping
  • 3.3 U.S. Cord Blood Banking Services Market -SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 3.4 Industry Analysis -Porter's
  • 3.5 Opportunity Analysis
    • 3.5.1 Opportunity Analysis: Placenta Storage
    • 3.5.2 Opportunity Analysis: Potential usage of Cord Tissue and Placenta Tissue in Regenerative Medicine Using Stem Cells
  • 3.6 Respository Analysis, By Bank Type, 2016

Chapter 4 U.S. Cord Blood Banking Services Market: Bank Type Estimates & Trend Analysis

  • 4.1 U.S. cord blood banking services market: Bank type movement analysis
  • 4.2 Private banks
    • 4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
    • 4.2.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
  • 4.3 Public bank
    • 4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
    • 4.3.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
  • 4.4 Hybrid
    • 4.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
    • 4.4.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)

Chapter 5 U.S. Cord Blood Banking Services Market: Blood Component Estimates & Trend Analysis

  • 5.1 U.S. cord blood banking services market: Blood component movement analysis
  • 5.2 Cord blood
    • 5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
    • 5.2.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
  • 5.3 Cord tissue
    • 5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
    • 5.3.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)
  • 5.4 Placenta
    • 5.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion)
    • 5.4.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units)

Chapter 6 U.S. Cord Blood Banking Services Market: Regional Estimates & Trend Analysis, By Bank Type & Blood Component

  • 6.1 U.S.
    • 6.1.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.1.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.2 Arizona
    • 6.2.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.2.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.3 California
    • 6.3.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.3.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.4 Florida
    • 6.4.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.4.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.5 Kentucky
    • 6.5.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.5.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.6 New Jersey
    • 6.6.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.6.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.7 Texas
    • 6.7.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.7.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.8 Houston
    • 6.8.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.8.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)
  • 6.9 Massachusetts
    • 6.9.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion)
    • 6.9.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion)

Chapter 7 Competitive Landscape

  • 7.1 Strategy framework
  • 7.2 Competitive Heat Map Analysis, by Region, 2016
  • 7.3 Company Profiles
    • 7.3.1 Cord Blood America, Inc.
      • 7.3.1.1 Company overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product benchmarking
      • 7.3.1.4 Strategic initiatives
    • 7.3.2 California Cryobank Stem Cell Services, LLC.
      • 7.3.2.1 Company overview
      • 7.3.2.2 Financial performance
      • 7.3.2.3 Product benchmarking
      • 7.3.2.4 Strategic initiatives
    • 7.3.3 StemCyte Inc.
      • 7.3.3.1 Company overview
      • 7.3.3.2 Financial performance
      • 7.3.3.3 Product benchmarking
      • 7.3.3.4 Strategic initiatives
    • 7.3.4 Cryo-Cell International, Inc.
      • 7.3.4.1 Company overview
      • 7.3.4.2 Financial performance
      • 7.3.4.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives
    • 7.3.5 Lifeforce Cryobank Sciences, Inc.
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
    • 7.3.6 Stem Cell Cryobank Inc.
      • 7.3.6.1 Company overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product benchmarking
    • 7.3.7 Norton Healthcare
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
      • 7.3.7.4 Strategic initiatives
    • 7.3.8 Viacord Processing Laboratory (VPL)
      • 7.3.8.1 Company overview
      • 7.3.8.2 Financial performance
      • 7.3.8.3 Product benchmarking
      • 7.3.8.4 Strategic initiatives
    • 7.3.9 New Jersey Cord Blood Bank
      • 7.3.9.1 Company overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.9.4 Strategic initiatives
    • 7.3.10 Carter BloodCare
      • 7.3.10.1 Company overview
      • 7.3.10.2 Financial performance
      • 7.3.10.3 Product benchmarking
      • 7.3.10.4 Strategic initiatives
    • 7.3.11 Americord Registry
      • 7.3.11.1 Company overview
      • 7.3.11.2 Financial performance
      • 7.3.11.3 Product benchmarking
      • 7.3.11.4 Strategic initiatives

List of Tables

  • TABLE 1 List of potential usage of cord blood
  • TABLE 2 Legislation implication in various states of the U.S. for cord blood banking services
  • TABLE 3 Cord Blood Facilities with AABB accreditation in the U.S.
  • TABLE 4 Differentiation potential of human placenta and amniotic fluid mesenchymal stem cells
  • TABLE 5 Private bank market, by volume, 2014 - 2025 (No. of Units)
  • TABLE 6 Public bank market, by volume, 2014 - 2025 (No. of Units)
  • TABLE 7 Hybrid market, by volume, 2014 - 2025 (No. of Units)
  • TABLE 8 U.S. cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 9 U.S. cord blood banking services market, by blood component, 2014 - 2025 (USD Billion)
  • TABLE 10 Arizona cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 11 California cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 12 Florida cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 13 Kentucky cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 14 New Jersey cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 15 Texas cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 16 Houston cord blood banking services market, by bank type, 2014 - 2025 (USD Billion)
  • TABLE 17 Massachusetts cord blood banking services market, by bank type, 2014 - 2025 (USD Billion

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary, 2016 (USD Billion)
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping, by Service
  • FIG. 13 Penetration & growth prospect mapping, by Component
  • FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 15 Porter's Five Forces Analysis
  • FIG. 16 Opportunity Analysis: Placenta Storage
  • FIG. 17 Differentiation potential of human placenta and umbilical cord blood stem cells
  • FIG. 18 Repository Analysis
  • FIG. 19 U.S. cord blood banking services market: Bank type outlook key takeaways
  • FIG. 20 U.S. cord blood banking services market: Bank type movement analysis
  • FIG. 21 Private bank market, 2014 - 2025 (USD Billion)
  • FIG. 22 Public bank market, 2014 - 2024 (USD Billion)
  • FIG. 23 Hybrid market, 2014 - 2024 (USD Billion)
  • FIG. 24 U.S. cord blood banking services market: Blood component outlook key takeaways
  • FIG. 25 U.S. cord blood banking services market: Blood component movement analysis
  • FIG. 26 Cord blood market, 2014 - 2024 (USD Billion)
  • FIG. 27 Cord tissue market, 2014 - 2025 (USD Billion)
  • FIG. 28 Placenta market, 2014 - 2025 (USD Billion)
  • FIG. 29 U.S. cord blood banking services market: Regional outlook key takeaways
  • FIG. 30 U.S. market, 2014 - 2025 (USD Billion)
  • FIG. 31 Arizona market, 2014 - 2025 (USD Billion)
  • FIG. 32 California market, 2014 - 2025 (USD Billion)
  • FIG. 33 Florida market, 2014 - 2025 (USD Billion)
  • FIG. 34 Kentucky market, 2014 - 2025 (USD Billion)
  • FIG. 35 New Jersey market, 2014 - 2025 (USD Billion)
  • FIG. 36 Texas market, 2014 - 2025 (USD Billion)
  • FIG. 37 Houston market, 2014 - 2025 (USD Billion)
  • FIG. 38 Massachusetts market, 2014 - 2025 (USD Billion)
  • FIG. 39 Strategy framework
  • FIG. 40 Heat map
Back to Top